Effect of probiotics on glucose metabolism in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials (Q26764758)

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Generation of hydrogen peroxide and failure of antioxidative responses in pancreatic islets of male C57BL/6 mice are associated with diabetes induced by multiple low doses of streptozotocin

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Consumption of Synbiotic Bread Decreases Triacylglycerol and VLDL Levels While Increasing HDL Levels in Serum from Patients with Type-2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Effects of the probiotic strain Lactobacillus johnsonii strain La1 on autonomic nerves and blood glucose in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Probiotic yogurt improves antioxidant status in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Oral Lactobacillus reuteri GMN-32 treatment reduces blood glucose concentrations and promotes cardiac function in rats with streptozotocin-induced diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Antioxidants and prevention of chronic disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Garlic in alloxan-induced diabetic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

The probiotic Lactobacillus acidophilus stimulates chloride/hydroxyl exchange activity in human intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Dietary combination of fish oil and taurine decreases fat accumulation and ameliorates blood glucose levels in type 2 diabetic/obese KK-A(y) mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Probiotic Pre-treatment Reduces Gliclazide Permeation (ex vivo) in Healthy Rats but Increases It in Diabetic Rats to the Level Seen in Untreated Healthy Rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Effectiveness of green tea in a randomized human cohort: relevance to diabetes and its complications

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Gut microbiota and the immune system: an intimate partnership in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Modulation of oxidative and antioxidative status in diabetes by asphaltum panjabinum.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Effects of combination of zinc and vitamin A supplementation on serum fasting blood sugar, insulin, apoprotein B and apoprotein A-I in patients with type I diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

The effects of tomato consumption on serum glucose, apolipoprotein B, apolipoprotein A-I, homocysteine and blood pressure in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021

Yogurt, living cultures, and gut health

1 reference

https://api.crossref.org/works/10.1016%2FJ.MEDICI.2015.11.008

7 January 2021